Brain, Vol. 110, No. 1, 35-51, 1987
© 1987 Oxford University Press
research-article |
PARKINSON'S DISEASE
COGNITIVE CHANGES IN RELATION TO TREATMENT RESPONSE
1From the Playfair Neuroscience Unit, University of Toronto 2From the Department of Anatomy, University of Toronto 3From the Department of Psychology, University of Toronto 4From the Institute of Medical Science, University of Toronto 5From the Department of Medicine, University of Toronto 6From the Department of Psychology, University of Toronto 7From the Department of Medicine, Division of Neurology, Toronto Western Hospital
Correspondence to:
Correspondence to: Dr J. A. Saint-Cyr, Playfair Neuroscience Unit, Toronto Western Hospital, 399 Bathurst Street, Toronto, Canada M5T 2S8.
Four groups of patients with Parkinson's disease matched for age, education and IQ were categorized by response to treatment and compared with a normal control group. The patient groups were (1) No Treatment (de novo); (2) Good Response (including minor fluctuations in symptoms); (3) Fluctuations (significant, including on-off phenomena) and/or marked Abnormal Involuntary Movements (dyskinesias); and (4) Poor Response (secondary treatment failure characterized by significant deterioration over time in all major symptoms). As a previous investigation had established that neuropsychological tests thought to be sensitive to the functional integrity of the frontal lobes are selectively impaired in Parkinson's disease, the first phase of this study compared the five groups on five such tests and two tests of psychomotor ability. While all patient groups displayed deficits on the psychomotor tests and on several tests associated with frontal lobe function compared with normals, only the Poor Response group was impaired on all tasks. In a second phase, comprehensive testing of additional cognitive processes such as attention, mnemonic, and visuospatial functions, the latter two traditionally thought to depend primarily on posterior cortical regions, revealed no significant cognitive deficits in any patient group. Results are discussed with respect to the involvement of the nigrostriatal and mesocortical dopaminergic systems.
Received December 3, 1985. Revised March 11, 1986. Accepted March 27, 1986.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Saint-Cyr, L. L. Trepanier, R. Kumar, A. M. Lozano, and A. E. Lang Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease Brain, October 1, 2000; 123(10): 2091 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. York, H. S. Levin, R. G. Grossman, and W. J. Hamilton Neuropsychological outcome following unilateral pallidotomy Brain, December 1, 1999; 122(12): 2209 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Perrine, M. Dogali, E. Fazzini, D. Sterio, E. Kolodny, D. Eidelberg, O. Devinsky, and A. Beric Cognitive functioning after pallidotomy for refractory Parkinson's disease J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 150 - 154. [Abstract] [Full Text] |
||||
![]() |
L. L. Trepanier, J. A. Saint-Cyr, A. M. Lozano, and A. E. Lang Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease Neurology, July 1, 1998; 51(1): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roane, J. D. Rogers, J. H. Robinson, and T. E. Feinberg Delusional Misidentification in Association With Parkinsonism J Neuropsychiatry Clin Neurosci, May 1, 1998; 10(2): 194 - 198. [Abstract] [Full Text] |
||||
![]() |
H. C. Chui Dementia: A Review Emphasizing Clinicopathologic Correlation and Brain-Behavior Relationships Arch Neurol, July 1, 1989; 46(7): 806 - 814. [Abstract] [PDF] |
||||




